Growth Hormone Deficiency Treatment Market: is Likely to Increase at a Significantly High CAGR during Forecast Period 2016 - 2022

Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of somatropin, a growth hormone, from the anterior pituitary gland which is responsible for the growth and cell reproduction. Though the exact cause of growth hormone deficiency is obscure, it is considered to be of genetic origin or also it can develop after a trauma, brain injury, due to pituitary tumors etc. Children with growth hormone deficiency show retarded growth and sometimes delayed puberty. Symptoms of growth hormone deficiency vary among adults and children. The predominant symptom in children is that the child is abnormally shorter than other children of his age with or without compromise in the cognitive intelligence while in adults, growth hormone deficiency may lead to fatigue, tiredness, anxiety and depression. Growth hormone deficiency is treated with growth hormone injections on daily or weekly basis although the effects of therapy starts showing after 2-3 months of therapy.

The primary factor contributing to the growth of global growth hormone deficiency treatment market is increasing incidence of growth hormone deficiency syndrome. Several other factors which may cause the global growth hormone deficiency market to grow include changing lifestyle, prevalence of other genetic disorders and incidence of GHD in adults. However, high cost of treatment will always remain the major restraint for global growth hormone deficiency treatment market.

Request for sample reports@ https://www.persistencemarketresearch.com/samples/9962

The global growth hormone deficiency treatment market has been segmented on the basis of treatment type, end user, retail sales channels and geography.

Based on treatment type, the global hyperpigmentation treatment market is divided into following:

• Pharmacological therapy
• Recombinant Human Growth Hormone
• Human pituitary gland extracts
• Surgery

Based on end user, the global hyperpigmentation treatment market is divided into following:

• Hospitals
• Clinics
• Home care settings

Based on retail sales channels, the global hyperpigmentation treatment market is divided into following:

• Pharmacy and drugstores
• Hospital pharmacy
• Online drug stores/email prescription stores

Surgeries in treatment of growth hormone deficiency treatment are rarely performed. Recombinant human growth hormone sub-segment of pharmacological therapy treatment type is expected to hold major share in the global growth hormone deficiency treatment market due to increased patient compliance. Home care settings’ end user segment occupies significant proportion of global growth hormone deficiency treatment market owing to the nature of a therapy requiring daily dosage administration. Introduction of new medicines such as Saizen solution is anticipated to expand the market growth of global growth hormone deficiency treatment market over the forecast period of 2016-2026.  

Geographically, the global growth hormone deficiency treatment market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.  North America is expected to contribute largest market share in global growth hormone deficiency treatment market followed by Europe. Emerging markets such as China, India, and Brazil are expected to present good opportunity for growth hormone deficiency treatment market due to entrance of key players into the market.

Request for TOC@ https://www.persistencemarketresearch.com/toc/9962

Some of the major players in the global growth hormone deficiency treatment market include Sandoz International GmbH, Sanofi Aventis, Pfizer, Novo Nordisk A/S, Teva Pharmaceutical Industries Limited, Ranbaxy, EMD Serono, Inc., Sun Pharmaceutical Industries Ltd., Eli Lilly and Company and others.

North America toxicology laboratories have been estimated to be valued at US$ 97.4 Mn in 2015, which is anticipated to increase to US$ 198.2 Mn revenue by 2022 at a CAGR of 11.1%.

Persistence Market Research delivers key insights on the North America Toxicology Laboratories Market in its latest outlook titled “North America Market Study on Toxicology Laboratories: Increasing Usage of Toxicology Testing Services in Crime Investigation is Expected to Drive the Growth of Toxicology Laboratories”.

The North America Toxicology Laboratories market is expected to reach US$ 198.2 Mn by the end of 2022 at a CAGR of 11.1% during the forecast period. On the basis of drug class, the North America toxicology laboratories market is segmented into alcohol, amphetamines, barbiturates, benzodiazepines, opiates/opioids, tricyclic antidepressants, and Z-Drugs. Weak regulatory control on prescription drugs with regard to over-the-counter purchases has been resulting in increased substance abuse and for amphetamines in particular. This increased consumption is fueling the demand for drug toxicology testing of amphetamines across the U.S. Amphetamines drug toxicity testing segment has been estimated to contribute highest in terms of revenue, accounting for 27.7% of the total toxicology laboratories market share in 2015. The opiate/opioids drug class segment has been estimated to be the fastest-growing segment of the North America toxicology laboratories market, registering a CAGR of 13.3% during the forecast period.

North America toxicology laboratories market is majorly driven by increasing abuse of controlled substances and drugs, increased expenditure by the government agencies on toxicity testing to control consumption of illegal drugs, and favorable reimbursement policies for conducting toxicity testing across workplaces. Additionally, commercial availability of high-end drug testing instruments, and economical, rapid, and effective methods to conduct drug testing is expected to drive the growth of the North America toxicology laboratories market. However, the introduction of point-of-care toxicology testing devices, longer wait time for sample testing in laboratories, and limited efficacy of conventional techniques are factors likely to impede the growth of the North America toxicology laboratories market over the forecast period.

Request for sample reports@ https://www.persistencemarketresearch.com/samples/9707

On the basis of sample type, the North America toxicology laboratories market is segmented into, urine, blood, hair, and oral fluid type segments. Urinalysis is one the most prominent techniques used to analyze toxicity in urine samples. This is due to its non-invasive approach, which promotes application in analyzing alcohol, opioids, and amphetamine drug traces and levels in samples. The urine sample segment has been estimated to account for ~62% revenue share in overall toxicology laboratories market in 2015.

The U.S. toxicology laboratories market has been estimated to account for over 83% revenue share of the overall North America toxicology laboratories market in 2015. This is attributed to substantially high levels of drug abuse and unregulated prescribing patterns for hallucination drugs such as amphetamines, barbiturates, benzodiazepines, tricyclic antidepressants, and Z Drugs.

Request for Methodology@  https://www.persistencemarketresearch.com/methodology/9707

The report begins with an overview of the North America toxicology laboratories market in terms of value, and a detailed analysis of key trends, drivers, and restraints, and opportunities, which are the main factors impelling growth of the toxicology laboratories market are covered in this section. Impact analysis of key growth drivers and restraints based on the weighted average of each of these factors in a model-based approach is included in the report. The report provides in-depth information on the potential scope of high-end confirmatory testing instruments to provide clients with crystal clear decision-making insights. 

Crohns Disease Treatment Market : reach US$ 4,474.8 Million by 2024-end, growing at a CAGR of 3% during the assessment period.

The Crohn’s & Colitis Foundation of America (CCFA) stated that over 1 Million Americans were diagnosed with Crohn's & ulcerative colitis disorders, with most of them aged above 30. Growing occurrence of Crohn's disease has triggered a robust demand for its therapeutics. A survey conducted by the US Center for Disease Control (CDC) has revealed that the incidence rate of Crohn's disease in the country is 3.1 to 14.6 new cases per 100,000 population annually. The disease is highly prevalent in developed countries, especially in individuals who smoke.  According to a study conducted by Persistence Market Research (PMR), demand for anti-inflammatory drugs and biologics for treating Crohn's disease will gain traction in the near future. PMR forecasts that the global market for Crohn's disease is set to reach US$ 4,474.8 Million by 2024-end, growing at a CAGR of 3% during the assessment period.

Request for sample reports@ https://www.persistencemarketresearch.com/samples/9665

Increasing demand for biologics for treating bowel disorders such as ulcerative collates and Crohn's disease is propelling the overall growth of Crohn's disease market. Moreover, drug manufacturers are actively focusing on advanced products having higher efficiency. The growing patient population is an additional factor expected to influence the market growth between 2016 and 2024. Therefore, higher utilization and preference for biologics and anti-inflammatory drug therapies coupled with the surging popularity of biosimilars is expected to play an important role in shaping the market for the future.

Bottlenecks

The high cost of treatment will remain as a major impediment for the market. Further, the patient expiry of blockbuster drugs and lack of early diagnosis particularly in third world countries are some of the other hindrances that are likely to inhibit the market growth during the forecast period.

Major Trends

Higher preference for symptomatic therapeutic and drugs over surgeries, better treatment management of inflammatory bowel diseases, the arrival of enhanced drugs in the market owing to healthier investments in R&D programs are some of the key trends governing the market.

Market Overview

While biologics will continue to remain the most preferred drug type amongst both healthcare professionals and patients, the demand for anti-inflammatory drugs will also witness a rampant acceleration during the forecast period. Based on drug type, the anti-inflammatory drug segment is projected to reach a market valuation of US$ 1,095.9 Million by end of the assessment period.

Based on distribution channel, the hospital pharmacies will continue to be the leading segment of the market over the forecast period. Whereas, the retail pharmacies segment is projected to exhibit the highest growth, reaching a market valuation of US$ 1,470.2 Million by 2024.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/9665

PMR’s findings based on regional assessment suggest that the Crohn's disease market in North America will continue to lead the pack during the forecast period. The region’s market is expected to value US$ 3,149.8 Million over 2014. However, Asia-Pacific is expected to witness the highest CAGR over the forecast period. The APAC market is projected to create an absolute $ opportunity of US$ 13.2 Million in 2017 over 2016.

Ether Carboxylates Market is Likely to Increase at a Significantly High CAGR during Forecast Period 2015 - 2021

Ether carboxylate is one of the major sub-types of a carboxylate which is produced from the reaction of ethoxylated alcohols with sodium chloracetate. Its manufacturing process involves etherification where a carboxyl group-containing compound and a hydroxyl group-containing compound are reacted in an aqueous medium with the help of a rare earth element containing catalyst. The carboxyl group containing compound present in the reaction is one compound which is selected from carboxyl group containing epoxy compounds as well as unsaturated carboxyl group containing compounds. Ether carboxylates are widely used in personal care products, surfactants, admixtures applied in the construction as well as serve as the vital component of superplasticizers. As surfactants, ether carboxylate produces an ultralow interfacial tension (IFT) under high temperature and high salinity conditions. Their consumption in the textile industry is based on their electrolyte, alkali, and hard water stability as well as their good wetting and detergent properties. As compared to cold process soaps, ether carboxylates are less sensitive to hard water and more soluble in water. In addition, they impart good wetting and foam stabilizing properties as well as provide creaminess and mildness in the finished products. Owing to their property of being substantive to hair and skin, ether carboxylate exhibits a conditioned feeling to the human body. When combined with alkyl ether sulfates such as sodium laureth sulfate, they are used for manufacturing shampoos on account of their compatibility with cationic ingredients. 

The global market for ether carboxylate has been witnessing a significant increase on account of growth of its application industries such as personal care and surfactants. Ether carboxylate shares a wide application scope in various industries such as soaps, detergents, textiles, shampoos, and plasticizers among others. In addition, bio-based surfactants has emerged as one of the major opportunities for the growth of the surfactant industry due to growing awareness among consumers towards eco-friendly products which in turn has contributed towards the growing demand for ether carboxylate in surfactants. Major applications of ether carboxylate-based surfactants include detergents, pharmaceuticals, textile and personal care among others. 

Request for sample reports@ https://www.persistencemarketresearch.com/samples/4292

Other applications of ether carboxylate include the manufacturing of plasticizers. The market for ether carboxylate in plasticizer has been witnessing significant growth on account of emerging economies and changing lifestyles. In addition, rising environmental awareness coupled with increasing legal provisions have been serving as catalysts for the plasticizers market in certain emerging economies such as India, China, Russia and Brazil. While matured regions such as North America and Europe accounted for the highest demand for ether carboxylate due to presence of vast and skin care and hair care industries, emerging regions such as Asia Pacific are anticipated to witness the fastest growth over the next few years on account of vast textile industries in economies such as China as well as growing demand for personal care products. Various factors such as rising awareness regarding healthy hair and skin among consumers as well as changing lifestyles are expected to boost the demand for personal care products which in turn is anticipated to contribute towards the demand for ether carboxylate. Growing demand for personal care products such as skin care and hair care on account of increasing awareness for healthy skin and hair is anticipated to be on the major factors driving the market for ether carboxylate. However, fluctuating prices of key feedstock materials has been major concern for the manufacturers and is expected to limit the growth of the market. Focus on commercializing and developing cost-effective bio-based surfactants using ether carboxylate is anticipated to provide new opportunities for the growth of the market. 

Request for TOC@ https://www.persistencemarketresearch.com/toc/4292

BASF SE, Huntsman Corporation, KAO Corporation, and Nippon Shokubai Co., Ltd. are some of the key manufacturers of ether carboxylate present in the market. 

Patient Handling Equipments Market is Likely to Increase at a Significantly High CAGR during Forecast Period 2015 to 2021

Patient handling comprises the lifting, lowering, holding, pushing, or pulling of patients. Patient handling equipments are mobility, disability, and rehabilitation equipments specifically designed to provide comfort and quality of sleep to hospitalized patients and cater to their other healthcare needs. These medical equipment provide flexibility and relaxation to the patient. The increasing prevalence of lifestyle diseases and the growing elderly population are the major driving factors for the patient handling equipments market in Europe. Healthcare organizations are increasing the adoption of patient handling equipment to avoid the injuries often caused by manual handling. Patient handling tasks includes transferring, lifting, and repositioning (turning patients in bed, giving patients baths on the bed, patient dressings, etc.) Patient handling equipment include stretchers, I.V. poles and accessories, operating table pads, armboard pads, wheelchair, medical beds, and scooters. Stretchers, wheelchairs, and scooters are used for moving patients who require medical care. Medical beds allow patients to change position for comfort and provide a comfortable sleep environment. 

The patient handling equipment market in Europe is segmented based on the type of care, end user, product, and accessories. Based on the type of care, the market covers bariatric care, prevention from accidental falls, critical care, wound care, and others. Based on the type of product, the market comprises wheelchairs and scooters, medical beds, bathroom safety supplies, mechanical lifting equipments and nonmechanical lifting equipments, ambulatory aids, and others. The wheelchair segment is further subdivided into manual wheelchairs and powered wheelchairs. The medical beds segment includes curative care beds, psychiatric care beds, long-term care beds, and others. Based on the accessories, the market covers lifting accessories, transfer accessories, evacuation accessories, stretcher accessories, hospital-bed accessories, and others. Based on end users, the market comprises hospitals, nursing homes, clinics, elderly care facilities, home care facilities, academic research institutes, and others. The medical bed segment accounts for the largest share of the patient handling equipment market in Europe. 

Request for sample reports@ https://www.persistencemarketresearch.com/samples/4281

The U.K. has the largest market for patient handling equipment in Europe, followed by Germany. This is due to increasing prevalence of lifestyle diseases, rising demand for patient handling equipments, and various initiatives taken by government programs to promote safe patient handling. Also, disabilities from noncommunicable diseases, a growing aging population, increased healthcare expenditure, and improved healthcare infrastructure support the growth of the patient handling equipment market in the U.K.

A growing geriatric population, the increasing prevalence of chronic diseases, technological advances, an increasing number of healthcare establishments, and demand for better healthcare services are major drivers for the patient handling equipments market in Europe. Moreover, an increasing number of hospitalization cases, rising healthcare expenditure, and growing need for multifunctional and affordable medical equipment are other factors supporting the growth of the patient handling equipment market in Europe. However, a dearth of trained medical professionals to handle patients in critical condition obstructs the growth of the market.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/4281

Increasing numbers of mergers and acquisitions, a rise in the number of collaborations and partnerships, and rapid product launches are some of the latest trends in the patient handling equipments market in Europe. Some of the major companies operating in the market are Linet, Inc., Handicare, Inc., Benmor Medical Ltd, ArjoHuntleigh, Inc., Spectra Care Group, Etac Ltd., Guldmann, Inc., Stiegelmeyer, Inc., Mangar International Ltd., and Sidhil Ltd.

Immune Health Supplements Market

The global immune health supplements market is expected to expand at a CAGR of 7.0% in terms of value during the eight year period between 2017 and 2025. According to the new report published by Persistence Market Research titled, “Immune Health Supplements Market: Global Industry Analysis (2012–2016) & Forecast (2017–2025),” North America is the largest market for immune health supplements, attributable to a rise in the number of health conscious consumers. Consumers in this region are willing to pay more for products that are organic, GMO-free, and vitamin and mineral fortified, thus creating lucrative market opportunities for immune health supplements manufacturers.

Global Immune Health Supplements Market: Trends

• Increasing availability of immune health supplements across hypermarkets and drug stores
• Growing demand for natural products and expanded focus towards preventive care
• Investments by health and wellness companies towards R&D
• Customization for specific regions
• Global e-Commerce growth
• Focus by key market players on broadening the customer base and on new product development

Global Immune Health Supplements Market: Forecast by Region

The five key geographies of North America, Latin America, Europe, APAC and MEA have been covered in this report. North America is estimated to account for around 36.7% share in terms of value in the global immune health supplements market in 2017. The market in APAC is projected to witness rapid growth and register a CAGR of 8.3% over the forecast period, owing to changing lifestyles of people, increasing urbanization, along with the growing health consciousness among the population. The rapidly growing aging population along with the prevalence of chronic diseases is expected to create profitable market opportunities for immune health supplements manufacturers in the aforementioned regions during the forecast period.

Request for sample reports@ https://www.persistencemarketresearch.com/samples/5852

Global Immune Health Supplements Market: Forecast by Ingredient Type

On the basis of ingredient type, the global immune health supplements market is segmented into vitamins, minerals, herbal/botanical extracts, amino acids, probiotics, Omega-3 fatty acids, and others. By ingredient type, the vitamins segment is expected to gain traction in the coming years due to the antioxidant feature of vitamins that helps the body fight against infections, along with supporting biochemical reactions in the immune system. This segment accounts for a high revenue share in the global immune health supplements market, and is expected to register a substantial growth rate during the forecast period. Furthermore, with increasing concerns about the side effects of chemicals and synthetic additives used in food and beverages, consumers are inclined towards natural alternatives. This particular factor is improving the demand for customized products or natural alternatives for established variants in the market.

Global Immune Health Supplements Market: Forecast by Form

Soft gels/pills, tablets, powder and liquid are the segments by form in the global immune health supplements market. The soft gels/pills segment is expected to show a relatively high market attractiveness index over the forecast period. The soft gels/pills segment is expected to register a CAGR of 6.7% during the forecast period. This segment is estimated to account for a relatively high value share of 38.1% by 2017 end.

Global Immune Health Supplements Market: Forecast by Sales Channel

Segmentation by sales channel includes online retailing and store based retailing. Store based retailing is sub-segmented into hypermarket/supermarket, pharmacies & drug stores, independent health stores and others. The store based retailing segment is expected to register a CAGR of 6.7% during the forecast period. The segment is estimated to account for a relatively high value share of 69.7% by 2017 end.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/5852

Global Immune Health Supplements Market: Forecast by Source Type

By source type, the global market is segmented into plant-based and animal-based source types. With more than 60% revenue share, the plant-based segment is expected to lead the global market and register a CAGR of 7.4% during the forecast period. On the other hand, the animal-based segment is likely to grab just about 36.8% revenue share of the global immune health supplements market. 

Australia New Zealand Surgical Respirator Masks Market

According to a new market report published by Persistence Market Research, titled “Australia and New Zealand Market Study on Surgical and Respirator Masks: Australia to Witness Highest Growth by 2021”, the surgical and respiratory mask market in Australia and New Zealand is expected to reach US$137.8 Mn by the end of 2015 and is anticipated to expand at a CAGR of 3.3% from 2015 to 2021, to reach US$167.7 Mn by 2021.

Surgical and respiratory masks can be defined as medical devices that are used to cover mouth, nose and chin, in order to protect the healthcare professionals and patients against droplets, including large respiratory particles. Surgical and respiratory masks are mainly used in hospitals and day surgery centres by physicians, independent dental surgeons, veterinary surgeons and life science professionals.

Request for sample reports@ https://www.persistencemarketresearch.com/samples/5684

Presently, the surgical and respiratory mask market in Australia and New Zealand is mainly driven by factors such as the increasing number of surgical procedures, rising health and hygiene concerns, and product innovation. However, factors such as logistics and distribution channel formulation saturated the market with unmet consumer needs, limited product availability, and competition between large multinational and local players are expected to restrain the growth of the market. The surgical and respiratory mask market in Australia and New Zealand is anticipated to expand at a CAGR of 3.3 % from 2015 to 2021, to reach US$ 167.7 Mn by 2021.

The Australia surgical and respirator mask market is expected to dominate the entire market in Australia and New Zealand by the end of 2015. The market is expected to be valued atUS$ 106.2 Mn by the end of 2015. The surgical and respirator mask market in New Zealand is expected to be valued at US$ 31.6 Man by the end of 2015 and is expected to expand at a CAGR of 3.2% during the forecast period. 

Request for Methodology@     https://www.persistencemarketresearch.com/methodology/5684